KIDOLIPO365 · HAPV
REVISED REVIEW · VERSION 03 · 13 SEPTEMBER 2026

Nine products · Three clear benefit roles

Benefits a parent can recognise.

A simpler positioning proposal built around bones, teeth, immunity, movement, cognitive function and normal energy release. Each icon is tied to a specific nutrient role and an EU-authorised claim.

Drops: 6–24 months · 30 mLSuspension: 24 months–12 years · 150 mL
Compare the nine productsView supporting EU claims
Proposed short captions and parent explanations. Select a benefit to see its full claim, nutrient attribution and limits. The three columns form a proposed pack strip, not a recommendation to give every product to every child.
Product & leading roleBenefit 1Benefit 2Benefit 3
01

Vitamin D

Bones and teeth as children grow.

Normal bone growth1.1For the normal growth and development of children’s bones.Teeth support1.2Helps maintain normal teeth.Immune support1.3Supports the normal function of a child’s immune system.
02

Magnesium

Normal muscles for everyday movement.

Muscle function2.1Normal muscles for everyday movement.Nerve function2.2Supports the nerves involved in normal body function.Reduced tiredness2.3Contributes to reducing tiredness and fatigue.
03

Vitamin C

Everyday immune function, plus dietary iron use.

Immune support3.1Supports normal immune function.FeIron absorption3.2Helps the body absorb iron from the diet.Gum support3.3Supports collagen formation for normal gum function.
04

Zinc

Cognitive support, with skin and immune support.

Cognitive Support4.1Supports normal cognitive function.Skin support4.2Helps maintain normal skin.Immune support4.3Supports normal immune function.
05

Vitamin B12

Normal energy release and red blood cell formation.

Normal energy release5.1Helps normal energy-yielding metabolism.Red blood cell formation5.2Supports the normal formation of red blood cells.Nerve function5.3Supports the nerves involved in normal body function.
06

Vitamin C + D + Zinc

Immune-led support, with bone growth and reduced tiredness.

Immune support6.1Immune function is the leading message for this combination.Normal bone growth6.2For the normal growth and development of children’s bones.Reduced tiredness6.3Contributes to reducing tiredness and fatigue.
07

Vitamin D + K2

Bone support from vitamin D and vitamin K.

Bone support7.1Vitamin D for normal bone growth; vitamin K for normal bone maintenance.Teeth support7.2Helps maintain normal teeth.Muscle function7.3Helps maintain normal muscle function.
08

Iron

Cognitive development, blood formation and energy metabolism.

Cognitive development8.1Contributes to children’s normal cognitive development.Red blood cell formation8.2Supports normal red blood cell and haemoglobin formation.Energy metabolism8.3Contributes to normal energy-yielding metabolism.
09

Omega 3

Brain function, vision support and heart function.

Brain function9.1DHA helps maintain normal brain function.Vision support9.2DHA helps maintain normal vision.Heart function9.3EPA and DHA contribute to normal heart function.

Different product stories, with honest overlap.

Each SKU has three different roles. Some roles recur across products because the nutrients share authorised functions. This version follows the revised direction: parent relevance takes priority over forcing 27 unique benefits.

Vitamin D and D + K2 naturally overlap. Their ingredient composition distinguishes them; the table does not invent a superior growth benefit for the combination. The C + D + Zinc combination also does not imply greater immune protection.

The familiar shield, bone, tooth, arm, head and blood-cell motifs are illustration proposals. They must remain beside their qualifying text, without disease symbols, performance promises or regulatory approval badges.

The wording behind each benefit

The exact nutrient claim supports the short caption. Short captions are proposed copy and should accompany the specific nutrient claim; wording equivalence remains subject to review.

Vitamin D

The simplest bone-growth story, with teeth and immune function as supporting roles.

Age and positioning note: Bone-growth and immune claims are explicitly child-specific. This does not establish suitability of an unconfirmed infant dose.

Magnesium

Movement leads; normal nerve function and reduced tiredness complete the story.

Age and positioning note: This is a stronger older-child story. Do not force the same tiredness-led positioning onto 6–24-month drops.

Vitamin C

An immune-led option with a clear food-related role and gum support.

Age and positioning note: The gum caption needs the collagen explanation. General claims are not automatically cleared for the infant presentation.

Zinc

Cognitive Support is the short caption for normal cognitive function.

Age and positioning note: The cognitive caption is provisional and especially relevant to older-child communication. It must not imply greater intelligence or infant cognitive development.

Vitamin B12

A recognisable energy-and-blood story, supported by normal nerve function.

Age and positioning note: Do not imply that every tired child needs B12, or that the product treats anaemia or a neurological condition.

Vitamin C + D + Zinc

Three familiar roles within one formulation; no claim of greater benefit than the individual nutrients.

Age and positioning note: Reduced tiredness is an older-child candidate. For infant drops, only retain a caption after age and formulation review; three slots are not compulsory.

Vitamin D + K2

Bones lead, with normal teeth and muscle function as supporting roles.

Age and positioning note: Overlap with vitamin D is real. Differentiate through the actual D + K formulation, not an invented superior growth or calcium-routing claim.

Iron

The three benefit roles from the reference pack, supported by the corresponding nutrient claims.

Age and positioning note: The cognitive-development claim explicitly refers to children; the blood-formation and energy claims are general-function claims. For drops (6–24 months) and suspension (24 months–12 years), confirm elemental iron per daily serving, age suitability and market requirements separately. These claims do not establish suitability of an unconfirmed infant dose or authorise an anaemia-treatment claim.

Omega 3

The three reference-pack roles, attributed specifically to DHA or EPA + DHA.

Age and positioning note: The three reference-pack claims are general-function claims, not infant-development claims. Assess the 6–24-month drops separately for 6–12 months and over 12–24 months; the separate DHA infant visual-development claim ends at 12 months. Neither drops nor the 24-month–12-year suspension is cleared until DHA and EPA quantities, age suitability and all claim conditions are confirmed. The intake figures shown describe claim conditions, not a recommended dose for a child.

One shared qualification for every selection

Official sources

  1. Regulation (EU) 432/2012 — general vitamin and mineral claims and conditions, consolidated 20 August 2025
  2. Regulation (EU) 2016/1389 — vitamin D and immune function in children
  3. Regulation (EC) 983/2009 — vitamin D and normal bone growth in children
  4. Regulation (EC) 1924/2006 — health claims, implied graphic claims and labelling conditions
  5. Regulation (EU) 957/2010 — iron and normal cognitive development of children
  6. Regulation (EU) 440/2011 — age-limited DHA infant visual-development claim
  7. European Commission guidance — section III.2.2, general and child-specific claims

Checked 13 September 2026. The official legal acts govern use. Iron and Omega 3 reference-pack roles are included as conditional proposals; adding them does not confirm eligibility of the final products.